Thyroid Gland Medullary Carcinoma clinical trials at UCSF
1 in progress, 0 open to new patients
Sorry, in progress, not accepting new patients
This phase I trial studies the side effects and best dose of cabozantinib S-malate in treating younger patients with solid tumors that have come back or no longer respond to treatment. Cabozantinib S-malate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
San Francisco, California and other locations